Singular Genomics

Singular Genomics

生物技术研究

San Diego,California 33,631 位关注者

Accelerating multiomics for the advancement of science and medicine.

关于我们

Singular Genomics is driving innovation at the forefront of multiomics. Dedicated to supporting the scientific community, we focus on creating scientific advancements influenced by real-world feedback and solution-oriented development. As a publicly-traded life science technology company, we specialize in advanced next-generation sequencing (NGS) and multiomic technologies, developing products that empower researchers and clinicians. The G4 Sequencing Platform, our first commercially available product, is an innovative benchtop sequencer featuring a novel 4-color rapid sequencing-by-synthesis (SBS) chemistry and advanced engineering, providing single-day turnaround times for various applications. Our recently launched G4X Spatial Sequencer, which is an upgrade to the G4 Sequencing Platform, is designed to offer high throughput in situ direct sequencing of RNA (Direct-Seq?), targeted transcriptomics, and proteomics profiling from formalin-fixed, paraffin-embedded (FFPE) tissues. We are committed to unlocking the potential of our core technologies to reshape the future of multiomics. We offer a dynamic, fast-paced, results-oriented environment where employees can make a significant impact. Innovation, continuous learning, multi-disciplinary collaboration, and diversity of thought are pillars of our culture.

网站
https://singulargenomics.com/
所属行业
生物技术研究
规模
201-500 人
总部
San Diego,California
类型
上市公司
创立
2016
领域
Biotechnology、Genomics、Research和Sequencing

地点

  • 主要

    3010 Science Park Rd

    US,California,San Diego,92121

    获取路线

Singular Genomics员工

动态

相似主页

查看职位

融资

Singular Genomics 共 3 轮

上一轮

可转债

US$130,500,000.00

Crunchbase 上查看更多信息